Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01633567 · ClinicalTrials.gov registry record · NA

Culturally Targeted & Individually Tailored Smoking Cessation Study: LGBT Smokers

A NA study, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
400
Enrollment target

NCT01633567 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 400 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01633567, a NA study, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
400 participants
Enrollment target

Study Summary

For the approximately 4.6 million LGBT persons in the U.S., smoking rates among those living in urban areas are roughly twice that of heterosexuals. Targeted interventions have shown great promise in reducing health risk behaviors across a variety of behaviors and population groups by enhancing the relevance of the health information. The primary aim of this study is to test the efficacy of a culturally targeted group-based smoking cessation intervention (vs. a non-targeted intervention) on smoking outcomes among lesbian, gay, bisexual, and transgender (LGBT) smokers. The investigators anticipate that the culturally targeted intervention will be more effective at helping LGBT smokers to successfully stop smoking than will the non-targeted intervention.

Interventions

  • BEHAVIORAL Culturally Targeted Cessation Program
  • BEHAVIORAL Non-Targeted Cessation Program

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2012-05
Est. Completion 2016-01
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT01633567

The ClinicalTrials.gov registry entry for NCT01633567 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Culturally Targeted Cessation Program is the first listed.

NCT01633567 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01633567 about?

NCT01633567 is a clinical study titled "Culturally Targeted & Individually Tailored Smoking Cessation Study: LGBT Smokers". For the approximately 4.6 million LGBT persons in the U.S., smoking rates among those living in urban areas are roughly twice that of heterosexuals. Targeted interventions have shown great promise in reducing health risk behaviors across a variety of behaviors and population groups by enhancing the ...

What is the current status of trial NCT01633567?

This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2012-05. Estimated completion is 2016-01.

What interventions are being tested in trial NCT01633567?

The interventions under investigation include: Culturally Targeted Cessation Program (BEHAVIORAL), Non-Targeted Cessation Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT01633567?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.